Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 150417-90-6 Chemical Structure| 150417-90-6

Structure of GC7 Sulfate
CAS No.: 150417-90-6

Chemical Structure| 150417-90-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GC7 Sulfate is an inhibitor targeting deoxyhypusine synthase (DHPS) with anti-pathogen activity, applied in the development of anti-infective drugs.

Synonyms: GC7 (sulfate); N1-Guanyl-1,7-diaminoheptane

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GC7 Sulfate

CAS No. :150417-90-6
Formula : C8H22N4O4S
M.W : 270.35
SMILES Code : NC(NCCCCCCCN)=N.O=S(O)(O)=O
Synonyms :
GC7 (sulfate); N1-Guanyl-1,7-diaminoheptane
MDL No. :MFCD31619261
InChI Key :MDDOWYFCKAAANU-UHFFFAOYSA-N
Pubchem ID :131842088

Safety of GC7 Sulfate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P280-P305+P351+P338-P310
Class:8
UN#:3263
Packing Group:

Related Pathways of GC7 Sulfate

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human THP-1 macrophages 20 µM 48 hours Inhibited M2-like macrophage polarization Cell Death Dis. 2023 Aug 31;14(8):579
Murine bone marrow-derived macrophages (BMDMs) 20 µM 48 hours Inhibited M2-like macrophage polarization Cell Death Dis. 2023 Aug 31;14(8):579
Human oral squamous cell carcinoma cells (Cal27) 10, 20, 40 µM 48 hours Inhibited cell proliferation and colony formation Cell Death Dis. 2023 Aug 31;14(8):579
LoVo 100 μM 24, 48, and 72 h Inhibition of CRC cell proliferation and EIF5A hypusination Cell Death Dis. 2020 Dec 10;11(12):1045
SW480 100 μM 24, 48, and 72 h Inhibition of CRC cell proliferation and EIF5A hypusination Cell Death Dis. 2020 Dec 10;11(12):1045
HCT116 100 μM 24, 48, and 72 h Inhibition of CRC cell proliferation and EIF5A hypusination Cell Death Dis. 2020 Dec 10;11(12):1045
HT29 100 μM 24, 48, and 72 h Inhibition of CRC cell proliferation and EIF5A hypusination Cell Death Dis. 2020 Dec 10;11(12):1045
B16-F10 cells 2.0 μM 24 hours Evaluate the effect of GC-7 on the survival rate of B16-F10 cells Adv Sci (Weinh). 2024 Sep;11(33):e2402450
SK-MEL-28 cells 2.0 μM 24 hours Evaluate the effect of GC-7 on the survival rate of SK-MEL-28 cells Adv Sci (Weinh). 2024 Sep;11(33):e2402450
A375 cells 2.0 μM 24 hours Evaluate the effect of GC-7 on the survival rate of A375 cells, results showed GC-7 had a smaller impact on cell survival at the same concentration Adv Sci (Weinh). 2024 Sep;11(33):e2402450
Mouse renal proximal convoluted tubule cells (PCT) 30 µM 24 hours GC7 treatment induced a decrease in eIF5A hypusination, shifting cell metabolism from oxidative phosphorylation to glycolysis, increasing glucose consumption and lactate efflux, while decreasing glucose uptake. Cell Death Dis. 2021 Mar 17;12(4):283
CD4 deficient PBMCs 100μM/mL 7 days To assess the ability of CD4 deficient PBMCs to convert into CD4+CD25+FOXP3+ Tregs under GC7+anti-DLL4 treatment. Results showed that 20.3±3.1% of CD8+ T cells converted into CD4+ T cells, with 45.6±8.8% further differentiating into CD4+CD25+FOXP3+ Tregs. Immunotargets Ther. 2025 Mar 13;14:205-226
CD4+CD25− T cells 100μM/mL 7 days To induce the conversion of CD4+CD25− T cells into CD4+CD25+FOXP3+ Tregs and evaluate their suppressive function. Results showed that 63.4±5.4% of CD4+CD25− T cells converted into CD4+CD25+ T cells with significant proliferative capacity. Immunotargets Ther. 2025 Mar 13;14:205-226
cortical neurons 30 μM 12 hours GC7 significantly reduced neuronal death induced by oxygen-glucose deprivation (OGD) and protected mitochondrial membrane potential and reduced ROS generation J Cereb Blood Flow Metab. 2021 May;41(5):1080-1090
Renal proximal convoluted tubule cells (PCT) 30 μM 8-hour pretreatment, exposed to anoxia 24 hours later GC7 pretreatment significantly enhanced PCT cell survival under anoxia, reduced CHOP nuclear translocation, and modulated ER stress pathways (increased xbp1 splicing and BiP expression, decreased eIF2α phosphorylation). Cells. 2023 Jan 25;12(3):409
HTR-8/SVneo cells 160 µM 24 hours Inhibits proliferation, migration and invasion of HTR-8 cells Cell Death Dis. 2018 Sep 11;9(9):926

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C3H mice Syngeneic orthotopic tongue OSCC model Intraperitoneal injection 20 mg/kg (first 3 days), 10 mg/kg (subsequently every 2 days) Once daily for the first 3 days, then every 2 days for 14 days Inhibited tumor growth and M2-like TAM infiltration Cell Death Dis. 2023 Aug 31;14(8):579
Nude mice A375 cell xenograft model Intraperitoneal injection 40 mg/kg Every 3 days for 18 days Evaluate the inhibitory effect of GC-7 on tumor growth, results showed GC-7 had a weaker inhibitory effect on tumor growth Adv Sci (Weinh). 2024 Sep;11(33):e2402450
Nude mice HCT116 xenograft model Intraperitoneal injection 4 mg/kg Daily for 15 days GC7 significantly decreased tumor growth and EIF5A hypusination Cell Death Dis. 2020 Dec 10;11(12):1045
Mouse C57BL/6 male mice Intraperitoneal injection 3 mg/kg Once daily for 3 days GC7 treatment reduced eIF5A hypusination in the kidney, decreased GLUT1 protein expression, and increased urinary glucose and lactate excretion without affecting renal function. Cell Death Dis. 2021 Mar 17;12(4):283
C57BL/6J mice Transient focal cerebral ischemia (tFCI) model Intraperitoneal injection 3 mg/kg Pretreatment: single or three injections at 48, 24, 2 h before; Post-treatment: sequential injections at 2 h, 2d, 4d, 7d, 10d, 14d, and 17d after GC7 significantly reduced brain infarct volume and improved motor and cognitive functional recovery J Cereb Blood Flow Metab. 2021 May;41(5):1080-1090

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.49mL

3.70mL

1.85mL

36.99mL

7.40mL

3.70mL

 

Historical Records

Categories